Live Breaking News & Updates on Inovio pharmaceuticals stock performance

Stay informed with the latest breaking news from Inovio pharmaceuticals stock performance on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Inovio pharmaceuticals stock performance and stay connected to the pulse of your community

Inovio Pharmaceuticals (NASDAQ:INO) Upgraded to Hold by StockNews.com

Inovio Pharmaceuticals (NASDAQ:INO) Upgraded to Hold by StockNews.com
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Canada , Inovio-pharmaceuticals-company-profile , Ci-private-wealth , Inovio-pharmaceuticals , Inovio-pharmaceuticals-stock-performance , News-ratings-for-inovio-pharmaceuticals-daily , Mirae-asset-global-investments-co , Inovio-pharmaceuticals-inc , Institutional-investors-weigh-in-on-inovio-pharmaceuticals , Royal-bank , Wealth-group

Short Interest in Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Declines By 5.8%

Inovio Pharmaceuticals, Inc. (NASDAQ:INO – Get Free Report) saw a large decrease in short interest in January. As of January 15th, there was short interest totalling 22,510,000 shares, a decrease of 5.8% from the December 31st total of 23,890,000 shares. Based on an average daily volume of 3,570,000 shares, the short-interest ratio is currently 6.3 […]

Vanguard-group-inc , Nasdaq , Metlife-investment-management , Hsbc-holdings , Charles-schwab-investment-management-inc , Inovio-pharmaceuticals , Renaissance-technologies , Inovio-pharmaceuticals-inc , News-ratings-for-inovio-pharmaceuticals-daily , Inovio-pharmaceuticals-company-profile , Inovio-pharmaceuticals-stock-performance

Inovio Pharmaceuticals (NASDAQ:INO) Upgraded to "Hold" by StockNews.com

StockNews.com upgraded shares of Inovio Pharmaceuticals (NASDAQ:INO – Free Report) from a sell rating to a hold rating in a report released on Thursday morning. INO has been the topic of several other research reports. JMP Securities began coverage on Inovio Pharmaceuticals in a research report on Thursday, January 4th. They set a market outperform […]

Vanguard-group-inc , Inovio-pharmaceuticals-stock-performance , Inovio-pharmaceuticals , Inovio-pharmaceuticals-inc , News-ratings-for-inovio-pharmaceuticals-daily , Blackrock-inc , Geode-capital-management , Renaissance-technologies , Free-report , Get-free-report , Street-corp

Inovio Pharmaceuticals (NASDAQ:INO) Stock Rating Upgraded by Oppenheimer

Inovio Pharmaceuticals (NASDAQ:INO – Get Free Report) was upgraded by research analysts at Oppenheimer from a “market perform” rating to an “outperform” rating in a research report issued to clients and investors on Thursday, MarketBeat Ratings reports. The firm presently has a $4.00 price objective on the biopharmaceutical company’s stock. A number of other brokerages […]

Inovio-pharmaceuticals-inc , Inovio-pharmaceuticals , Inovio-pharmaceuticals-stock-performance , Fund-management-co , E-fund-management-co , Hsbc-holdings , Nasdaq , News-ratings-for-inovio-pharmaceuticals-daily , Group-plc , Nuveen-asset-management , Get-free-report

Inovio Pharmaceuticals (NASDAQ:INO) Receives New Coverage from Analysts at StockNews.com

StockNews.com assumed coverage on shares of Inovio Pharmaceuticals (NASDAQ:INO – Free Report) in a research report released on Saturday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. Inovio Pharmaceuticals Stock Performance Shares of NASDAQ:INO opened at $0.42 on Friday. The stock has a fifty day simple moving average of $0.41 and […]

Group-plc , E-fund-management-co , Fund-management-co , Hedge-funds-weigh-in-on-inovio-pharmaceuticals , Inovio-pharmaceuticals , Nuveen-asset-management , Hsbc-holdings , Nasdaq , Inovio-pharmaceuticals-stock-performance , Inovio-pharmaceuticals-inc , News-ratings-for-inovio-pharmaceuticals-daily

Inovio Pharmaceuticals (NASDAQ:INO) Now Covered by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Inovio Pharmaceuticals (NASDAQ:INO – Free Report) in a research report released on Thursday. The firm issued a hold rating on the biopharmaceutical company’s stock. Inovio Pharmaceuticals Stock Performance Shares of INO opened at $0.51 on Thursday. The stock has a market cap of $137.47 million, a P/E ratio of […]

Beck-bode , Institutional-investors-weigh-in-on-inovio-pharmaceuticals , News-ratings-for-inovio-pharmaceuticals-daily , Allspring-global-investments-holdings , Inovio-pharmaceuticals-company-profile , Inovio-pharmaceuticals , Inovio-pharmaceuticals-inc , Inovio-pharmaceuticals-stock-performance , Capital-investment-advisors , Free-report , Get-free-report

Inovio Pharmaceuticals (NASDAQ:INO) Research Coverage Started at StockNews.com

StockNews.com began coverage on shares of Inovio Pharmaceuticals (NASDAQ:INO – Free Report) in a report published on Tuesday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Inovio Pharmaceuticals Stock Performance Shares of INO opened at $0.38 on Tuesday. The stock has a 50 day simple moving average of $0.44 and a […]

Hsbc-holdings , Group-plc , Inovio-pharmaceuticals-inc , Inovio-pharmaceuticals-stock-performance , Fund-management-co , News-ratings-for-inovio-pharmaceuticals-daily , E-fund-management-co , Institutional-investors-weigh-in-on-inovio-pharmaceuticals , Inovio-pharmaceuticals , Nuveen-asset-management , Inovio-pharmaceuticals-company-profile

Inovio Pharmaceuticals (NASDAQ:INO) Earns Sell Rating from Analysts at StockNews.com

StockNews.com initiated coverage on shares of Inovio Pharmaceuticals (NASDAQ:INO – Free Report) in a report issued on Monday. The firm issued a sell rating on the biopharmaceutical company’s stock. Inovio Pharmaceuticals Stock Performance INO stock opened at $0.39 on Monday. The stock has a market cap of $104.55 million, a P/E ratio of -0.60 and […]

Hedge-funds-weigh-in-on-inovio-pharmaceuticals , Inovio-pharmaceuticals-stock-performance , Renaissance-technologies , Inovio-pharmaceuticals , Inovio-pharmaceuticals-inc , Inovio-pharmaceuticals-company-profile , Vanguard-group-inc , News-ratings-for-inovio-pharmaceuticals-daily , Charles-schwab-investment-management-inc , Hsbc-holdings , Metlife-investment-management

Prime Capital Investment Advisors LLC Buys New Position in Inovio Pharmaceuticals, Inc. (NASDAQ:INO)

Prime Capital Investment Advisors LLC purchased a new position in shares of Inovio Pharmaceuticals, Inc. (NASDAQ:INO – Free Report) in the 1st quarter, HoldingsChannel reports. The firm purchased 34,802 shares of the biopharmaceutical company’s stock, valued at approximately $29,000. Other hedge funds and other institutional investors have also recently modified their holdings of the company. […]

Charles-schwab-investment-management-inc , Inovio-pharmaceuticals , Renaissance-technologies , News-ratings-for-inovio-pharmaceuticals-daily , Nasdaq , Inovio-pharmaceuticals-company-profile , Hsbc-holdings , Inovio-pharmaceuticals-inc , Capital-investment-advisors , Vanguard-group-inc , Inovio-pharmaceuticals-stock-performance

Inovio Pharmaceuticals (NASDAQ:INO) Coverage Initiated by Analysts at StockNews.com

Inovio Pharmaceuticals (NASDAQ:INO) Coverage Initiated by Analysts at StockNews.com
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Inovio-pharmaceuticals-stock-performance , Blackrock-inc , Renaissance-technologies , Inovio-pharmaceuticals-company-profile , Inovio-pharmaceuticals , Vanguard-group-inc , Inovio-pharmaceuticals-inc , News-ratings-for-inovio-pharmaceuticals-daily , Millennium-management , Free-report , Get-free-report